Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Lymphokines. Found 9 abstracts

Zhang L, Yang N, Katsaros D, Huang W, Park JW, Fracchioli S, Vezzani C, Rigault de la Longrais IA, Yao W, Rubin SC, Coukos G. The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma. Cancer Res. 2003 Jul 15;63(14):4225-31.
Zhang L, Yang N, Mohamed-Hadley A, Rubin SC, Coukos G. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem Biophys Res Commun. 2003 Apr 18;303(4):1169-78.
Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res. 2003 Jun 15;63(12):3403-12.
Cianfrocca M, Cooley TP, Lee JY, Rudek MA, Scadden DT, Ratner L, Pluda JM, Figg WD, Krown SE, Dezube BJ. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol. 2002 Jan;20(1):153-9.
Ma J, Reed KA, Gallo JM. Cells designed to deliver anticancer drugs by apoptosis. Cancer Res. 2002 Mar;62(5):1382-7.
Chao C, Al-Saleem T, Brooks JJ, Rogatko A, Kraybill WG, Eisenberg B. Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade. Ann Surg Oncol. 2001 Apr;8(3):260-7.
Cvetkovic D, Movsas B, Dicker AP, Hanlon AL, Greenberg RE, Chapman JD, Hanks GE, Tricoli JV. Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. Urology. 2001 Apr;57(4):821-5.
Hazelton DA, Hamilton TC. Vascular endothelial growth factor in ovarian cancer. Current oncology reports. 1999 Sep;1(1):59-63.
Ma J, Fei ZL, Klein-Szanto A, Gallo JM. Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor. Clin Exp Metastasis. 1998 Aug;16(6):559-68.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Lymphokines

Endothelial Growth Factors Lymphokines Human metabolism Female Pathologic Neovascularization pharmacology US Gov't Support-PHS Non-US Gov't Support Ovarian Neoplasms Male physiology blood supply genetics Vascular Endothelial Growth Factor A biosynthesis drug effects Vascular Endothelial Growth Factors Adult Intercellular Signaling Peptides and Proteins Middle Age Neoplastic Gene Expression Regulation Neoplasm Proteins Neoplasm RNA analysis Immunohistochemistry Carcinoma Animal Apoptosis Aged physiopathology complications Receptor Protein-Tyrosine Kinases Messenger RNA Prognosis Cultured Tumor Cells blood Antineoplastic Agents Mice Genetic Vectors Biological Tumor Markers pathology Cell Hypoxia Analysis of Variance Protein Isoforms Neoplasm Metastasis Transformed Cell Line Membrane Glycoproteins Inbred C57BL Mice Neoplasms Oral Administration Nucleic Acid Synthesis Inhibitors Sensitivity and Specificity Cell Division Luminescent Proteins Reporter Genes adverse effects 1-Phosphatidylinositol 3-Kinase Paracrine Communication Retrospective Studies HIV Infections Enzymologic Gene Expression Regulation Heterologous Transplantation RNA Interference TIE-2 Receptor Chromones Angiopoietin-1 Oxygen Kaposi Sarcoma Cytoplasm Transfection Alkylating Antineoplastic Agents Double-Stranded RNA antagonists & Adolescence diagnosis Glioma New York enzymology Dactinomycin Morpholines Philadelphia Carmustine inhibitors Antisense DNA Capillaries epidemiology Angiogenesis Inducing Agents Gelatinase B Matrix Metalloproteinases Soft Tissue Neoplasms Vascular Endothelium Rats Anoxia Drug Delivery Systems 80 and over Aged chemistry Recombinant Fusion Proteins Gelatinase A Disease-Free Survival secretion Local Neoplasm Recurrence drug therapy Tissue Engineering Survival Rate antagonists & inhibitors therapeutic use Nonparametric Statistics mortality Catalytic Domain Gene Therapy administration & dosage Transcription Factors Nude Rats Tissue Distribution Risk Assessment CD95 Antigens Proportional Hazards Models Dacarbazine Enzyme Inhibitors Pericytes Stromal Cells Prostatic Neoplasms Sarcoma Biological Models Epithelium Angiopoietin-2 Base Sequence Fibroblast Growth Factor 2 Paclitaxel Tetracycline therapy etiology Endothelium analogs & derivatives cytology Promoter Regions (Genetics) Cultured Cells Growth Factor Receptors
Last updated on Friday, January 03, 2020